Standard Operating Procedure for Cross-Functional Submission Readiness Reviews
| Department | Regulatory Affairs |
| SOP No. | RA/2026/785 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 17/04/2026 |
| Effective Date | 17/04/2026 |
| Review Date | 17/04/2028 |
Purpose
This Standard Operating Procedure (SOP) describes the process and controls necessary to conduct effective cross-functional submission readiness reviews for regulatory submissions. The objective is to ensure all departmental inputs, quality checks, and compliance requirements are met prior to submission, thus minimizing errors, ensuring regulatory adherence, and facilitating timely approvals.
Scope
This SOP applies to all regulatory submission activities involving cross-functional teams including Regulatory Affairs, Quality Assurance, Quality Control, Manufacturing, Engineering, and other relevant departments. It covers all types of regulatory submissions across any functional area, dosage form, process, equipment qualification, validation, calibration, documentation, and compliance activities. Non-regulatory document reviews not related to submission readiness are excluded.
Responsibilities
The following roles are responsible for the execution and oversight of the submission readiness review process:
- Regulatory Affairs Team: Coordinates and leads the review process, ensuring completeness of submission dossiers.
- Quality Assurance (QA): Reviews quality-related components and ensures compliance standards are met.
- Quality Control (QC): Provides analytical data validation and confirms documentation accuracy.
- Manufacturing and Engineering: Verify manufacturing process details, equipment qualification, and validations.
- Cross-functional Team Members: Contribute subject-matter expertise and validate their department’s data.
- Review Coordinator: Schedules meetings, tracks review progress, and documents outcomes.
Accountability
The Head of Regulatory Affairs is accountable for the implementation, compliance, periodic review, and continuous improvement of this SOP. This role ensures escalation of non-compliance issues and monitors effectiveness through regular metrics and audits.
Procedure
1. Preparation and Prerequisites:
The Regulatory Affairs team identifies upcoming submissions requiring cross-functional review and circulates a submission plan including timelines, dossier scope, and referenced standards. All participating departments nominate representatives with adequate expertise. Documentation and supporting data including batch records, validation reports, calibration certificates, and analytical results must be compiled and pre-checked for completeness.
2. Scheduling and Communication:
The Review Coordinator schedules cross-functional review meetings well in advance, ensuring key stakeholders’ availability. Meeting agendas and relevant documents are distributed to participants at least five business days prior to the review date.
3. Review Execution:
During the meetings, each department presents their inputs using the prepared documents. Reviews focus on compliance with regulatory guidelines, adequacy of technical data, consistency across sections, and identification of gaps or discrepancies.
- Check all validation and calibration records are current and compliant.
- Verify equipment qualification and cleaning records if applicable.
- Ensure manufacturing processes described align with actual practices documented.
- Confirm documentation adheres to GMP and internal quality standards.
4. In-Process Controls and Verification:
Any observations or non-conformances raised during reviews are logged, and responsible departments are assigned to address them within a defined timeline. Re-reviews are conducted if necessary prior to final submission approval.
5. Approval and Documentation:
Upon successful completion of the review and closure of all action items, Regulatory Affairs documents the final approval of the submission readiness. Records of meeting minutes, review comments, and corrective actions are maintained as per record retention policy.
6. Deviations and Escalations:
Any significant deviations from planned activities or unresolved critical findings must be escalated to the Head of Regulatory Affairs. Formal deviation reports are generated, investigated, and tracked until resolution.
7. Record Retention and Closure:
All documentation related to the cross-functional review, including supporting data, meeting records, and approvals, are archived per company document management policies and regulatory requirements. The review cycle is formally closed with a summary report and lessons learned where applicable.
This procedure is dynamic and can be adapted depending on the complexity of the submission and the specific regulatory requirements involved.
Abbreviations
GMP: Good Manufacturing Practice
QA: Quality Assurance
QC: Quality Control
RA: Regulatory Affairs
SOP: Standard Operating Procedure
CSV: Computer System Validation
Documents
The following documents are essential for conducting cross-functional submission readiness reviews:
- Submission Readiness Review Checklist (Annexure-1)
- Cross-Functional Review Meeting Minutes Template (Annexure-2)
- Submission Review Action Item Log (Annexure-3)
References
ICH Q10 – Pharmaceutical Quality System
FDA Guidance on Content of Chemistry, Manufacturing, and Controls (CMC) Sections
EU GMP Annex 11 – Computerized Systems
Internal Quality Management System Policies
Company Document and Record Control Procedures
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Submission Readiness Review Checklist
Purpose: To provide a structured checklist for verifying completeness and compliance of all submission dossier elements prior to cross-functional review.
| Check Item | Status (Yes/No) | Comments |
|---|---|---|
| All required sections completed | Yes | Complete per regulatory format |
| Validation reports included and approved | Yes | Validated per protocol |
| Equipment qualification documentation attached | Yes | Qualified per SOP EQ-105 |
| Analytical data reviewed and accepted | Yes | Reviewed by QC team |
| Cleaning records verified | Yes | Within acceptable limits |
| Deviation history included | No | None reported for this batch |
| Final signature page ready | Yes | Ready for approval |
Annexure-2: Cross-Functional Review Meeting Minutes Template
Purpose: To document the discussions, findings, action items, and approvals arising from the submission readiness review meetings.
| Meeting Date | 12/04/2026 |
| Meeting Location | Conference Room B |
| Attendees | Regulatory Affairs, QA, QC, Manufacturing, Engineering Representatives |
| Agenda | Review submission dossier for product ABC, address gaps, finalize readiness status |
| Discussion Point | Comments | Responsible Dept. | Due Date |
|---|---|---|---|
| Validation report clarification | Minor data discrepancy to be clarified | QA | 15/04/2026 |
| Cleaning record update | Additional signatures required on log | Manufacturing | 16/04/2026 |
| Analytical data confirmation | All data consistent and accepted | QC | N/A |
| Meeting Outcome | Submission ready pending completion of QA and Manufacturing updates. |
| Next Meeting Date | 18/04/2026 |
Annexure-3: Submission Review Action Item Log
Purpose: To track and document the status of actions arising from the cross-functional submission readiness review meetings.
| Action Item | Description | Responsible Department | Assigned To | Due Date | Status |
|---|---|---|---|---|---|
| 1 | Clarify discrepancy in validation report data | Quality Assurance | QA Analyst | 15/04/2026 | In Progress |
| 2 | Obtain missing signatures on cleaning logs | Manufacturing | Shift Supervisor | 16/04/2026 | Completed |
| 3 | Confirm final analytical results consistency | Quality Control | QC Analyst | 14/04/2026 | Completed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 17/04/2026 | 1.0 | Initial issue | New SOP creation |